MIRA
INFORM REPORT
|
Report Date : |
04.02.2014 |
IDENTIFICATION DETAILS
|
Name : |
AMSTELFARMA B.V. |
|
|
|
|
Registered Office : |
Zuiveringweg 40, 8243PZ Lelystad |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
01.11.1986 |
|
|
|
|
Com. Reg. No.: |
39064879 |
|
|
|
|
Legal Form : |
Private Company |
|
|
|
|
Line of Business : |
Manufacturer of pharmaceutical, infusion liquids, sutures, medical products & sundries. |
|
|
|
|
No. of Employees : |
14 (2012) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – december 01, 2013
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
Netherlands |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Netherlands ECONOMIC OVERVIEW
The Dutch economy is the
sixth-largest economy in the euro-zone and is noted for its stable industrial
relations, moderate unemployment and inflation, a sizable trade surplus, and an
important role as a European transportation hub. Industrial activity is
predominantly in food processing, chemicals, petroleum refining, and electrical
machinery. A highly mechanized agricultural sector employs only 2% of the labor
force but provides large surpluses for the food-processing industry and for
exports. The Netherlands, along with 11 of its EU partners, began circulating
the euro currency on 1 January 2002. After 26 years of uninterrupted economic
growth, the Dutch economy - highly dependent on an international financial
sector and international trade - contracted by 3.5% in 2009 as a result of the
global financial crisis. The Dutch financial sector suffered, due in part to
the high exposure of some Dutch banks to U.S. mortgage-backed securities. In
2008, the government nationalized two banks and injected billions of dollars of
capital into other financial institutions, to prevent further deterioration of
a crucial sector. The government also sought to boost the domestic economy by
accelerating infrastructure programs, offering corporate tax breaks for
employers to retain workers, and expanding export credit facilities. The
stimulus programs and bank bailouts, however, resulted in a government budget
deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7%
in 2008. The government of Prime Minister Mark RUTTE began implementing fiscal
consolidation measures in early 2011, mainly reductions in expenditures, which
resulted in an improved budget deficit in 2011. In 2012 tax revenues dropped
nearly 9%, GDP contracted, and the budget deficit deteriorated. Although
jobless claims continued to grow, the unemployment rate remained relatively low
at 6.8 percent.
Source : CIA
company Summary
Company name Amstelfarma B.V.
Operative address Zuiveringweg
40
8243PZ Lelystad
Netherlands
Status Active
Legal form Besloten
Vennootschap (Private Company)
Registration number KvK-nummer:
39064879
VAT-number
008620751
Year 2012
Fixed assets 96.741
Total receivables 4.006.462
Total equity 447.293
Short term liabilities 3.656.110
Working capital 350.552
Quick ratio 1,10
Contact information
Company name Amstelfarma
B.V.
Trade names Amstelfarma
Operative address Zuiveringweg
40
8243PZ Lelystad
Netherlands
Correspondence address Postbus
2200
8203AE Lelystad
Netherlands
Telephone number 023
5319052
Fax number 0320
219655
Email address info@amstelfarma.nl
Website
www.amstelfarma.nl
Registration
Registration number KvK-nummer:
39064879
Registered in Kamer
van Koophandel Gooi-, Eem- en Flevoland
Branch number 000008488819
VAT-number 008620751
Status Active
Memorandum 1986-12-29
Establishment date 1986-11-01
Legal form Besloten
Vennootschap (Private Company)
Last
proposed admendment 1992-04-14
Activities
Manufacturer of pharmaceutical, infusion liquids,
sutures, medical products & sundries.
Exporter No
Importer No
Goal Groothandel
in grondstoffen en producten in het algemeen en in chemische grondstoffen en
producten in het bijzonder;
alsmede het voeren van agentschappen en vertegenwoordigingen
terzake;
tevens houder van een produktievergunning. Pharmaceutische groothandel.
(Wholesale
of raw materials and products in general, and in chemicals and
products
in particular, as well as the conduct of agencies and offices
matter,
also holder of a production license. Pharmaceutical wholesaler.)
Relations
Shareholders Amstelfarma
Holding B.V.
Nijverheidsweg 37
2102LK HEEMSTEDE
Netherlands
Registration number: 558243900000
Percentage:
100.00%
Branches Amstelfarma
B.V.
Nijverheidsweg 37
2102LK HEEMSTEDE
Netherlands
Registration number: 390648790001
Liability statements Meervliet
Beheer B.V.
Zuiveringweg 40
8243PZ LELYSTAD
Netherlands
Registration number: 390648810000
date of issue: 2006-01-26
Starting date: 2005-01-01
End
date: 2012-09-14
Bank details
Accounts ABN
Amro Bank NV
Account number: 41.06.57.913
Management
Active management
Bogers Management B.V.
Nooit Gedacht 98
1398EG MUIDEN
Netherlands
Registration number: 341372080000
Competence: Fully authorized
Function: Manager
Starting date: 2012-09-25
Employees
Year 2012
2011 2008 2007 2006
Total 14 14
14 19 23
Payments
Description
Payments
made under regular condition
|
Year |
2012 |
|
Quick ratio |
1,10 |
|
Current ratio |
1,10 |
|
Working capital/ balance
total |
0,09 |
|
Equity / balance total |
0,11 |
|
Equity / Fixed assets |
4,62 |
|
Equity / liabilities |
0,12 |
|
Balance total / liabilities |
1,12 |
|
Working capital |
350.552 |
|
Equity |
447.293 |
Summary
The 2012 financial result structure is a postive working captial
of 350.552 euro, which is in
agreement with 9 % of the total assets of the company.
The current ratio of the company in 2012 was 1.1. When the
current ratio is below 1.5, the
company may have problems meeting its short-term
obligations.
The quick ratio in 2012 of the company was 1.1. A company
with a Quick Ratio of more than
1 can currently pay back its
current liabilities.
Financial statement
Type of annual account Corporate
Annual account Amstelfarma
B.V.
Zuiveringweg 40
8243PZ Lelystad
Netherlands
Registration
number: 390648790000
Balance sheet
Year 2012
End date 2012-12-31
Other tangible fixed assets 96.741
Tangible fixed assets 96.741
Fixed assets 96.741
Other receivables 4.006.462
Total receivables 4.006.462
Liquid funds 200
accruals 4.006.462
Current assets 4.006.662
Total assets 4.103.403
Total equity 447.293
Short term liabilities 3.656.110
Total short and long term liabilities 3.656.110
Total liabilities 4.103.403
Summary
In 2012 the assets of the company were 2.36 % composed of
fixed assets and 97.64 % by
current assets. The assets are being financed by an equity
of 10.9 %, and total debt of 89.1
%.
Analysis
Branch (SBI) Groothandel
en Wholesale on a fee or contract basis (niet in auto’s en motorfietsen) (46)
Region Flevoland
In the Netherlands 107516 of
the companies are registered with the SBI code 46
In the region Flevoland 2863
of the companies are registered with the SBI code 46
In the Netherlands 2108 of the
bankrupcties are published within this sector
In the region Flevoland 77 of
the bankruptcies are published within this sector
The risk of this specific
sector in the Netherlands is normal
The risk of this specific
sector in the region Flevoland is normal
Publications
Consent statements
01-11-2012: Voor boekjaar 2011 is een
instemmingsverklaring gedeponeerd.
16-05-2012: Voor boekjaar 2010 is een
instemmingsverklaring gedeponeerd.
08-09-2010: Voor boekjaar 2009 is een
instemmingsverklaring gedeponeerd.
Liability statements
17-09-2012: Per 14-09-2012 is een
aansprakelijkheidsverklaring door Meervliet Beheer B.V. ingetrokken.
Filings
08-10-2013: De jaarrekening over 2012 is gepubliceerd.
Functions
15-03-2013: Per 25-09-2012 is gevolmachtigde Johannes
Jacobus Maria van Haperen in functie getreden.
14-03-2013: Per 01-09-2011 is gevolmachtigde Josine
Hoekstra-Voogd in functie getreden.
28-09-2012: Per 25-09-2012 is bestuurder 34137208 Bogers
Management B.V. in functie getreden.
28-09-2012: Per 25-09-2012 is bestuurder Johan Lambert van
den Brink uit functie getreden.
28-09-2012: Per 25-09-2012 is gevolmachtigde Nicolaas
Cornelis Theodorus Roozendaal uit functie getreden.
28-09-2012: Per 25-09-2012 is gevolmachtigde Josine
Hoekstra-Voogd uit functie getreden.
28-09-2012: Per 25-09-2012 is gevolmachtigde Johannes
Jacobus Maria van Haperen uit functie getreden.
15-11-2011: Per 01-09-2011 is bestuurder Nicolaas Cornelis
Theodorus Roozendaal uit functie getreden.
15-11-2011: Per 01-09-2011 is gevolmachtigde Johan Lambert
van den Brink uit functie getreden.
04-11-2011: Per 01-09-2011 is gevolmachtigde Nicolaas
Cornelis Theodorus Roozendaal in functie getreden.
04-11-2011: Per 01-09-2011 is bestuurder Johan Lambert van
den Brink in functie getreden.
Amendments
08-12-2011: Per 1-9-2011 is de bevoegdheid van Bestuurder
Johan Lambert van den Brink gewijzigd.
Company structure
Relations 5
Bogers Management B.V.
Nooit Gedacht 98
1398EG MUIDEN
Netherlands
Registration number: 341372080000
Amstelfarma Holding B.V.
Nijverheidsweg 37
2102LK HEEMSTEDE
Netherlands
Registration number: 558243900000
Amstelfarma B.V.
Zuiveringweg 40
8243PZ Lelystad
Netherlands
Registration number:
390648790000
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.69 |
|
UK Pound |
1 |
Rs.102.97 |
|
Euro |
1 |
Rs.84.58 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.